Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $847M (100.0% shares, 0.0% debt)

Holdings (32)

— Onyx Pharmaceuticals, Inc. 13.6%
Value $115M Shares 1,325,115 Share Price $86.82 Est. Cost/Share $86.82 Unrealized @ Report Date —
— ViroPharma Incorporated 13.4%
Value $114M Shares 3,968,818 Share Price $28.65 Est. Cost/Share $28.65 Unrealized @ Report Date —
— Cyberonics, Inc. 11.4%
Value $96.81M Shares 1,863,118 Share Price $51.96 Est. Cost/Share $51.96 Unrealized @ Report Date —
UTHR United Therapeutics Corp 7.0%
Value $59.29M Shares 900,778 Share Price $65.82 * Est. Cost/Share $64.42 Unrealized @ Report Date 0.0%
— Abiomed Inc. 5.9%
Value $50.01M Shares 2,319,398 Share Price $21.56 Est. Cost/Share $21.56 Unrealized @ Report Date —
— Auxilium Pharmaceuticals, Inc. 5.6%
Value $47.36M Shares 2,847,842 Share Price $16.63 Est. Cost/Share $16.63 Unrealized @ Report Date —
BMRN Biomarin Pharmaceuticals, Inc 5.2%
Value $43.87M Shares 787,119 Share Price $55.74 * Est. Cost/Share $62.32 Unrealized @ Report Date 0.0%
— AMAG Pharmaceuticals, Inc. 4.4%
Value $37.4M Shares 1,680,871 Share Price $22.25 Est. Cost/Share $22.25 Unrealized @ Report Date —
— Cubist Pharmaceuticals, Inc. 4.3%
Value $36.55M Shares 756,821 Share Price $48.29 Est. Cost/Share $48.29 Unrealized @ Report Date —
— Sequenom Inc. 4.1%
Value $34.53M Shares 8,202,692 Share Price $4.21 Est. Cost/Share $4.21 Unrealized @ Report Date —
STAA STAAR Surgical Company 3.8%
Value $32.59M Shares 3,211,318 Share Price $10.15 * Est. Cost/Share $8.10 Unrealized @ Report Date 0.0%
— Questcor Pharmaceuticals, Inc. 3.7%
Value $31.64M Shares 696,297 Share Price $45.44 Est. Cost/Share $45.44 Unrealized @ Report Date —
VNDA Vanda Pharmaceutical Inc. 2.3%
Value $19.25M Shares 2,381,876 Share Price $8.08 * Est. Cost/Share $6.73 Unrealized @ Report Date 0.0%
— Alimera Sciences, Inc. 2.1%
Value $17.74M Shares 3,634,984 Share Price $4.88 Est. Cost/Share $4.88 Unrealized @ Report Date —
— Momenta Pharmaceuticals, Inc. 2.1%
Value $17.7M Shares 1,175,076 Share Price $15.06 Est. Cost/Share $15.06 Unrealized @ Report Date —
— Intermune Inc. 2.0%
Value $17.08M Shares 1,775,485 Share Price $9.62 Est. Cost/Share $9.62 Unrealized @ Report Date —
— Rigel Pharmaceuticals Inc. 1.6%
Value $13.14M Shares 3,935,576 Share Price $3.34 Est. Cost/Share $3.34 Unrealized @ Report Date —
FOLD Amicus Therapeutics, Inc. 1.3%
Value $10.77M Shares 4,622,230 Share Price $2.33 * Est. Cost/Share $3.07 Unrealized @ Report Date 0.0%
— Anacor Pharmaceuticals, Inc. 1.1%
Value $9.043M Shares 1,617,651 Share Price $5.59 Est. Cost/Share $5.59 Unrealized @ Report Date —
— AVEO Pharmaceuticals, Inc. 1.0%
Value $8.773M Shares 3,509,205 Share Price $2.50 Est. Cost/Share $2.50 Unrealized @ Report Date —
— QLT Inc. 1.0%
Value $8.563M Shares 1,950,636 Share Price $4.39 Est. Cost/Share $4.39 Unrealized @ Report Date —
— Savient Pharmaceuticals, Inc. 0.6%
Value $5.457M Shares 9,744,833 Share Price $0.56 Est. Cost/Share $0.56 Unrealized @ Report Date —
INSM Insmed, Inc. 0.4%
Value $3.185M Shares 266,299 Share Price $11.96 * Est. Cost/Share $10.22 Unrealized @ Report Date 0.0%
— Aegerion Pharmaceuticals Inc. 0.4%
Value $3.106M Shares 49,040 Share Price $63.34 Est. Cost/Share $63.34 Unrealized @ Report Date —
— Cytokinetics Inc. 0.4%
Value $3.026M Shares 261,544 Share Price $11.57 Est. Cost/Share $11.57 Unrealized @ Report Date —
— Spectrum Pharmaceuticals Inc. 0.3%
Value $2.954M Shares 395,985 Share Price $7.46 Est. Cost/Share $7.46 Unrealized @ Report Date —
— Kythera BioPharm CMN 0.3%
Value $2.332M Shares 86,201 Share Price $27.05 Est. Cost/Share $27.05 Unrealized @ Report Date —
— Xoma Ltd. 0.2%
Value $1.897M Shares 522,683 Share Price $3.63 Est. Cost/Share $3.63 Unrealized @ Report Date —
— Hyperion Therapeutics 0.2%
Value $1.839M Shares 83,600 Share Price $22.00 Est. Cost/Share $22.00 Unrealized @ Report Date —
PRTA Prothena Corp PLC 0.1%
Value $1.143M Shares 88,500 Share Price $12.92 * Est. Cost/Share $9.30 Unrealized @ Report Date 0.0%
— Dendreon Corp 0.1%
Value $856K Shares 207,800 Share Price $4.12 Est. Cost/Share $4.12 Unrealized @ Report Date —
— NxStage Medical, Inc. 0.1%
Value $630K Shares 44,129 Share Price $14.28 Est. Cost/Share $14.28 Unrealized @ Report Date —